Grimes & Company, Inc. reports 64.68% increase in ownership of ABL / Abbott Laboratories

Abbott Laboratories

DE ˙ XTRA ˙ US0028241000

75,22 € ↑1,20 (1,62%)

2026-06-03
DEL PRIS

Security	DE:ABL / Abbott Laboratories
Institution	Grimes & Company, Inc.
Latest Disclosed Ownership	119,936 shares
Latest Disclosed Value	$ 12,313,859

On April 21, 2026 - Grimes & Company, Inc. filed a 13F-HR form disclosing ownership of 119,936 shares of Abbott Laboratories (DE:ABL) valued at $10,652,716 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 72,828 shares of Abbott Laboratories. This represents a change in shares of 64.68% during the quarter. The current value of the position is $9,021,586 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-21	2026-03-31	13F	ABBOTT LABORATORIES	COM	002824100	119,936	47,108	64.68	12,314	34.95	0.3409
2026-02-03	2025-12-31	13F	ABBOTT LABS	COM	002824100	72,828	2,404	3.41	9,125	-3.27	0.2180
2025-10-27	2025-09-30	13F	ABBOTT LABS	COM	002824100	70,424	10,635	17.79	9,433	16.00	0.2329
2025-07-22	2025-06-30	13F	ABBOTT LABS	COM	002824100	59,789	814	1.38	8,132	3.94	0.2213
2025-04-17	2025-03-31	13F	ABBOTT LABS	COM	002824100	58,975	851	1.46	7,823	19.00	0.2418
2025-01-21	2024-12-31	13F	ABBOTT LABS	COM	002824100	58,124	179	0.31	6,574	-0.48	0.1894
2024-10-22	2024-09-30	13F	ABBOTT LABS	COM	002824100	57,945	1,188	2.09	6,606	12.02	0.1788
2024-07-22	2024-06-30	13F	ABBOTT LABS	COM	002824100	56,757	-219	-0.38	5,898	-8.93	0.1765
2024-04-17	2024-03-31	13F	ABBOTT LABS	COM	002824100	56,976	-58	-0.10	6,476	3.15	0.1991
2024-01-24	2023-12-31	13F	ABBOTT LABS	COM	002824100	57,034	2,481	4.55	6,278	18.82	0.2078
2023-10-19	2023-09-30	13F	ABBOTT LABS	COM	002824100	54,553	228	0.42	5,283	-10.79	0.2043
2023-07-19	2023-06-30	13F	ABBOTT LABS	COM	002824100	54,325	-135	-0.25	5,923	7.40	0.2100
2023-04-20	2023-03-31	13F	ABBOTT LABS	COM	002824100	54,460	20	0.04	5,515	-7.75	0.2260
2023-01-25	2022-12-31	13F	ABBOTT LABS	COM	002824100	54,440	11	0.02	5,977	13.48	0.2523
2022-10-28	2022-09-30	13F	ABBOTT LABS	COM	002824100	54,429	-162	-0.30	5,267	-11.20	0.2749
2022-07-22	2022-06-30	13F	ABBOTT LABS	COM	002824100	54,591	113	0.21	5,931	-8.02	0.2991
2022-05-06	2022-03-31	13F	ABBOTT LABS	COM	002824100	54,478	14	0.03	6,448	-15.88	0.3012
2022-02-01	2021-12-31	13F	ABBOTT LABS	COM	002824100	54,464	-1,174	-2.11	7,665	16.63	0.3509
2021-11-08	2021-09-30	13F	ABBOTT LABS	COM	002824100	55,638	122	0.22	6,572	2.11	0.2860
2021-08-04	2021-06-30	13F	ABBOTT LABS	COM	002824100	55,516	-98	-0.18	6,436	-3.44	0.2792
2021-05-12	2021-03-31	13F	ABBOTT LABS	COM	002824100	55,614	7,975	16.74	6,665	27.78	0.3205
2021-02-02	2020-12-31	13F	Abbott Laboratories	COM	002824100	47,639	0	0.00	5,216	0.60	0.2710
2020-11-12	2020-09-30	13F	Abbott Laboratories	COM	002824100	47,639	-11	-0.02	5,185	19.00	0.3316
2020-07-31	2020-06-30	13F	Abbott Laboratories	COM	002824100	47,650	59	0.12	4,357	16.03	0.3028
2020-05-05	2020-03-31	13F	Abbott Laboratories	COM	002824100	47,591	2,003	4.39	3,755	-5.18	0.3427
2020-02-05	2019-12-31	13F	Abbott Laboratories	COM	002824100	45,588	158	0.35	3,960	4.18	0.2594
2019-11-05	2019-09-30	13F	Abbott Laboratories	COM	002824100	45,430	-550	-1.20	3,801	-1.71	0.2708
2019-07-30	2019-06-30	13F	Abbott Laboratories	COM	002824100	45,980	161	0.35	3,867	5.57	0.2935
2019-05-02	2019-03-31	13F	Abbott Laboratories	COM	002824100	45,819	-39	-0.09	3,663	10.43	0.2871
2019-02-01	2018-12-31	13F	Abbott Laboratories	COM	002824100	45,858	-95	-0.21	3,317	-1.60	0.3237
2018-11-09	2018-09-30	13F	Abbott Laboratories	COM	002824100	45,953	-133	-0.29	3,371	19.92	0.2699
2018-08-10	2018-06-30	13F	Abbott Laboratories	COM	002824100	46,086	750	1.65	2,811	3.46	0.2484
2018-05-07	2018-03-31	13F	Abbott Laboratories	COM	002824100	45,336	11,138	32.57	2,717	39.19	0.2632
2018-02-05	2017-12-31	13F	Abbott Laboratories	COM	002824100	34,198	30,186	752.39	1,952	812.15	0.1884
2017-11-03	2017-09-30	13F	Abbott Laboratories	COM	002824100	4,012	4,012		214		0.0228

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.